Global Deterioration Scale: Difference between revisions
(Created page with "{{subst: Under Construction}} {{subst: Outcome Measures}}") |
(Objective & Intended Population) |
||
| Line 3: | Line 3: | ||
</div> | </div> | ||
<div class="editorbox"> | <div class="editorbox"> | ||
'''Original Editor '''- [[User: | '''Original Editor '''- [[User:Carina Therese Magtibay|Carina Therese Magtibay]] | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}} | ||
</div> | </div> | ||
== Objective< | == Objective == | ||
The Global Deterioration Scale (GDS), also known as Reisberg Scale, is an [[Outcome Measures|outcome measure]] used to determine the stages of cognitive function among patients diagnosed with primary degenerative dementia. It helps caregivers/ healthcare professionals assess the progression and prognosis of the disease.<ref>Reisberg B, Ferris SH, de Leon MJ, Crook T. [https://pubmed.ncbi.nlm.nih.gov/7114305/ The Global Deterioration Scale for assessment of primary degenerative dementia]. The American journal of psychiatry. 1982 Sep.</ref> | |||
== Intended Population | == Intended Population == | ||
This screening tool is intended for patients with '''primary degenerative [[dementia]] such as [[Alzheimer's Disease|Alzheimer’s disease]].''' | |||
== Method of Use | == Method of Use == | ||
The GDS is classified into 7 stages according to a set of clinical characteristics: | |||
== Reference<br> == | == Reference<br> == | ||
Revision as of 15:33, 26 March 2023
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (26/03/2023)
Original Editor - Carina Therese Magtibay
Top Contributors - Carina Therese Magtibay
Objective[edit | edit source]
The Global Deterioration Scale (GDS), also known as Reisberg Scale, is an outcome measure used to determine the stages of cognitive function among patients diagnosed with primary degenerative dementia. It helps caregivers/ healthcare professionals assess the progression and prognosis of the disease.[1]
Intended Population[edit | edit source]
This screening tool is intended for patients with primary degenerative dementia such as Alzheimer’s disease.
Method of Use[edit | edit source]
The GDS is classified into 7 stages according to a set of clinical characteristics:
Reference
[edit | edit source]
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous
[edit | edit source]
Links[edit | edit source]
References[edit | edit source]
- ↑ Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. The American journal of psychiatry. 1982 Sep.
